New and experimental therapies for treating graft-versus-host disease
Open Access
- 30 June 1995
- journal article
- review article
- Published by Elsevier in Blood Reviews
- Vol. 9 (2) , 117-133
- https://doi.org/10.1016/s0268-960x(95)90031-4
Abstract
No abstract availableThis publication has 95 references indexed in Scilit:
- THE USE OF MONOCLONAL ANTIBODIES IN ALLOGENEIC BONE MARROW TRANSPLANTATIONBritish Journal of Haematology, 1993
- Pathogenesis and recent therapeutic approaches to graft-versus-host diseaseThe Journal of Pediatrics, 1991
- Photochemotherapy improves chronic cutaneous graft-versus-host diseaseJournal of the American Academy of Dermatology, 1990
- Serum Cyclosporine Concentration and Risk of Acute Graft-versus-Host Disease after Allogeneic Marrow TransplantationNew England Journal of Medicine, 1988
- Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for LeukemiaNew England Journal of Medicine, 1986
- Marrow Transplantation from Related Donors Other Than HLA-Identical SiblingsNew England Journal of Medicine, 1985
- Methoxsalen and ultraviolet A radiation in treatment of chronic cutaneous graft-versus-host reactionJournal of the American Academy of Dermatology, 1985
- Murine monoclonal anti-T cell antibodies for treatment of steroid-resistant acute graft-versus-host diseaseHuman Immunology, 1984
- A Randomized Study of the Prevention of Acute Graft-versus-Host DiseaseNew England Journal of Medicine, 1982
- BONE MARROW TRANSPLANTATION IN PATIENTS WITH LEUKEMIATransplantation, 1971